Quick summary: Desmopressin Nasal Sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). - Notice to Hospitals .
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Quick summary: Desmopressin Nasal Sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). - Notice to Hospitals .
Detailed identifiers are not available here. Review the official notice before deciding whether your product is affected.
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Answers based on the official recall notice.
Official product images from Health Canada.
Starting...
Similar recalls and safety notices.